RESULTS AND DISCUSSION
The synthesis of II exploits the principle of nucleophilic substitution on an activated heterocycle. The method is generally referred to as Vicarious Nucleophilic Substitution or the VNS method. 13 The latter is a novel way of introducing an -functionalized alkyl chain onto activated aromatic rings. 13 Although electron-rich 5-membered nitrogen heterocycles such as imidazoles do not normally undergo nucleophilic substitution reactions, the introduction of strong electron-withdrawing groups such as a nitro functionality can render them vulnerable to such reactions.
The synthesis started with 4-nitroimidazole (Scheme 1), and the first step was to protect the N-H of imidazole with a benzyl group; in this case, para-methoxybenzyl chloride was employed for reasons described under Introduction above. Treatment of 4-nitroimidazole with para-methoxybenzyl chloride and potassium carbonate in DMF yielded 1-p-methoxybenzyl-4-nitroimidazole (2) as a colorless crystalline solid in 90% yield. Compound 2 was subjected to VNS using chloroform and potassium t-butoxide in DMF to yield the target 5-dichloromethyl-1-p-methoxybenzyl-4-nitroimidazole (II) in 60% yield. The 1 H-NMR of II in deuterated dimethyl sulfoxide revealed the proton of 5-dichloromethyl group as a singlet at 7.96, and the imidazole ring proton at 8.01 also as a singlet. The elemental microanalysis was consistent and the mass spectrum showed the correct MH + ion at m/z 316. A mechanism for the formation of II from 2 by the VNS method is outlined in Scheme 2. The first step, most likely the rate determining, involves the nucleophilic attack of the carbanion formed from chloroform onto position 5 of the imidazole ring. The subsequent base-catalyzed elimination of hydrogen chloride, followed by reprotonation of the dichloromethylene carbon atom and the ring aromatization produces II. The presence of a nitro group on the imidazole ring is apparently critical for the VNS method to succeed.
Compound II was reacted with two representative amine nuclephiles, including benzylamine and N-hydroxylamine (Scheme 3). The products 3 and 4, obtained in 44% and 63% yields, respectively, were fully characterized by spectroscopic and microanalytical data.
Our final goal was to demonstrate the feasibility of employing II for the synthesis of "fat" nucleosides. To this end, we decided to further explore the reactivity of 4 with alkylating agents, which, if reacted successfully, would yield product with the appropriate carbon fragment attached that would afford the 5:7 heterocyclic ring system upon ring closure.
However
is believed to be the inactivation of the oxime nitrogen atom because of conjugation with the electron-withdrawing nitro group attached at the 4-position of the imidazole ring. In order to alleviate this problem, we then decided to reduce the nitro group into an amino group before carrying out the necessary alkylation or acylation reactions.
The reduction of 4 was carried out in a Parr hydrogenation apparatus, using 10% Palladium and charcoal in ethanol at 40 psi of hydrogen gas to afford the desired amine 5 in 71% yield (Scheme 5). Compound 5 was reacted with dichloroacetyl chloride to obtain 4-(2,2-dichloroacetyl)amino-5-(N-hydroxyiminomethylene)-1-pmethoxybenzylimidazole (6) as a crystalline solid in 74% yield. The 1 H NMR of 6 exhibited the presence of D 2 O-exchangeable amide NH as well as the N-OH functionalities integrating for a proton each at 11.24 and 10.54 , respectively, suggesting that the reaction had taken place at the 4-amino function intead of the oxime nitrogen atom. Compound 6 was a suitable precursor for the synthesis of a representative "fat" nucleobase Indeed, the ring-closure of 6 with sodium methoxide in methanol produced the novel, 5:7-fused heterocycle III, albeit in somewhat low (34%) yield. The reason for the relatively poor yield of this reaction is not yet clear, although optimum reaction conditions for this last synthetic step are yet to be worked out. It is also not obvious as to when the methanolysis of the halide group(s) takes place, whether before or after the ring-closure. In any case, compound III, with its interesting N-oxide structure, bears a broad scope for further chemical, biochemical, biological, as well as chemotherapeutic explorations Because of their intriguing physicochemical properties, coupled with their unique biological behavior, the heterocyclic N-oxides have earned the separate classification as an independent, unique family of organic compounds. [66] [67] [68] [69] [70] [71] [72] [73] 
Conclusion and Future Work
The synthesis of the target imidazole derivative, 5-dichloromethyl-1-p-methoxybenzyl-4-nitroimidazole (II), has been accomplished. Compound II is a key imidazole precursor for the synthesis of a wide variety of old as well as new "fat" nucleobases and nucleosides. The synthesis of II is short, convenient, reasonably good-yielding, and can be prepared on a large scale from readily available and inexpensive starting materials. Furthermore, the dichloromethyl functionality of II is anticipated to be amenable for easy conversion into a number of other reactive functional groups including, but not limited to, a carboxaldehyde, a carboxylic acid, aor an iminomethylene group. We have further demonstrated the use of II in future "fat" nucleoside syntheses by successfully synthesizing a representative "fat" nucleobase III.
